Recurrent wheezing in children following human metapneumovirus infection

Andrea M. Coverstone; Brad Wilson; Dana Burgdorf; Kenneth B. Schechtman; Gregory A. Storch; Michael J. Holtzman; Mario Castro; Leonard B. Bacharier; Kaharu Sumino

doi:10.1016/j.jaci.2018.02.008

Recurrent wheezing in children following human metapneumovirus infection

Andrea M. Coverstone, Brad Wilson, Dana Burgdorf, Kenneth B. Schechtman, Gregory A. Storch, Michael J. Holtzman, Mario Castro, Leonard B. Bacharier, Kaharu Sumino

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Original language	English
Pages (from-to)	297-301.e2
Journal	Journal of Allergy and Clinical Immunology
Volume	142
Issue number	1
DOIs	https://doi.org/10.1016/j.jaci.2018.02.008
State	Published - Jul 2018

Access to Document

10.1016/j.jaci.2018.02.008

Cite this

@article{4d8fd9b30bad4024b4e9cb06623f7897,

title = "Recurrent wheezing in children following human metapneumovirus infection",

author = "Coverstone, {Andrea M.} and Brad Wilson and Dana Burgdorf and Schechtman, {Kenneth B.} and Storch, {Gregory A.} and Holtzman, {Michael J.} and Mario Castro and Bacharier, {Leonard B.} and Kaharu Sumino",

note = "Funding Information: Disclosure of potential conflict of interest: A. M. Coverstone reports grants from the National Institutes of HNIH) to Kaharu Sumino/Washington University in St Louis. M. Castro reports grants from the NIH, American Lung Association during the conduct of the study; personal fees from Aviragen, Boehringer Ingelheim, Boston Scientific, Elsevier, Genentech, GSK, Holaira, and Teva; and grants from Amgen, Boehringer Ingelheim, Genentech, Gilead, GlaxoSmithKline, Invion, Medimmune, Sanofi-Aventis, and Vectura. L. B. Bacharier reports grants from the NIH; personal fees from Aerocrine, GlaxoSmithKline, Genentech/Novartis, Merck, Cephalon, DBV Technologies, Teva, Boehringer Ingelheim, AstraZeneca, WebMD/Medscape, Sanofi/Regeneron, Vectura, and Circassia. The rest of the authors declare that they have no relevant conflicts of interest. Funding Information: This work was supported by the National Institutes of Health (grant no. 1KM1CA156708-1 to K.S.), the National Institute of Allergy and Infectious Diseases (grant no. U19 AI070489), and the National Center for Advancing Translational Sciences (grant no. 5UL1 TR000448-07). ",

year = "2018",

month = jul,

doi = "10.1016/j.jaci.2018.02.008",

language = "English",

volume = "142",

pages = "297--301.e2",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

number = "1",

}

Recurrent wheezing in children following human metapneumovirus infection. / Coverstone, Andrea M.; Wilson, Brad; Burgdorf, Dana; Schechtman, Kenneth B.; Storch, Gregory A.; Holtzman, Michael J.; Castro, Mario; Bacharier, Leonard B.; Sumino, Kaharu.

In: Journal of Allergy and Clinical Immunology, Vol. 142, No. 1, 07.2018, p. 297-301.e2.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Recurrent wheezing in children following human metapneumovirus infection

AU - Coverstone, Andrea M.

AU - Wilson, Brad

AU - Burgdorf, Dana

AU - Schechtman, Kenneth B.

AU - Storch, Gregory A.

AU - Holtzman, Michael J.

AU - Castro, Mario

AU - Bacharier, Leonard B.

AU - Sumino, Kaharu

N1 - Funding Information: Disclosure of potential conflict of interest: A. M. Coverstone reports grants from the National Institutes of HNIH) to Kaharu Sumino/Washington University in St Louis. M. Castro reports grants from the NIH, American Lung Association during the conduct of the study; personal fees from Aviragen, Boehringer Ingelheim, Boston Scientific, Elsevier, Genentech, GSK, Holaira, and Teva; and grants from Amgen, Boehringer Ingelheim, Genentech, Gilead, GlaxoSmithKline, Invion, Medimmune, Sanofi-Aventis, and Vectura. L. B. Bacharier reports grants from the NIH; personal fees from Aerocrine, GlaxoSmithKline, Genentech/Novartis, Merck, Cephalon, DBV Technologies, Teva, Boehringer Ingelheim, AstraZeneca, WebMD/Medscape, Sanofi/Regeneron, Vectura, and Circassia. The rest of the authors declare that they have no relevant conflicts of interest. Funding Information: This work was supported by the National Institutes of Health (grant no. 1KM1CA156708-1 to K.S.), the National Institute of Allergy and Infectious Diseases (grant no. U19 AI070489), and the National Center for Advancing Translational Sciences (grant no. 5UL1 TR000448-07).

PY - 2018/7

Y1 - 2018/7

UR - http://www.scopus.com/inward/record.url?scp=85044273208&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2018.02.008

DO - 10.1016/j.jaci.2018.02.008

M3 - Article

C2 - 29481834

AN - SCOPUS:85044273208

VL - 142

SP - 297-301.e2

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 1

ER -

Recurrent wheezing in children following human metapneumovirus infection

Access to Document

Other files and links

Cite this